Kinoxis Therapeutics Pty Ltd

As sales of Jardiance continue to soar, Boehringer Ingelheim GmbH is making good use of the revenues from the blockbuster to advance its pipeline, especially in the oncology space. The family-owned

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novartis Buys Cystinosis Gene Therapy F